Written by the Nuvirox Research Team
Key points
- Surgery and general anesthesia trigger oxidative stress and NAD+/SIRT1 pathway disruption in the brain, which researchers believe contributes to postoperative cognitive dysfunction (POCD) and delirium.
- Animal studies testing NAD+ precursors around surgery and anesthesia are genuinely mixed — including at least one study that found no benefit for anesthetic recovery at all.
- There is no published human trial testing NAD+ precursor supplementation for surgical recovery or postoperative cognitive outcomes.
Short answer: the mechanism is plausible and actively studied in animals, but the animal results themselves are mixed, and there's no human surgical-recovery trial to point to.
Why would NAD+ matter around surgery?
General anesthesia and the physiological stress of surgery are known to disrupt mitochondrial function and increase oxidative stress in the brain, contributing to postoperative cognitive dysfunction (POCD) and, in older or frail patients particularly, postoperative delirium. Researchers have specifically implicated declining NAD+-dependent SIRT1 activity in this process, since SIRT1 normally helps restrain the oxidative stress response. This has made NAD+ precursors a logical, if early-stage, research target for reducing these surgical complications.
What does the evidence actually show?
Preclinical research offers a genuinely mixed picture. On one hand, nicotinamide mononucleotide pretreatment improved long-term isoflurane-anesthesia-induced cognitive impairment in mice by reducing oxidative stress. Similarly, nicotinamide (NAM) pretreatment prevented surgery-induced synaptic plasticity impairments and cognitive dysfunction in a mouse bone-fracture-surgery model of postoperative delirium, working through reduced neuroinflammation and CD38/SIRT1 signaling. On the other hand, a separate, more recent study specifically testing NAD+ itself for anesthetic recovery in rodents found it did not improve anesthetic recovery — a direct, published negative result worth taking seriously rather than glossing over.
Study snapshot: Mixed animal evidence on NAD+ and surgical/anesthesia recovery
| Positive finding 1 | NMN pretreatment improved isoflurane-induced cognitive impairment (mice) |
| Positive finding 2 | Nicotinamide prevented surgery-induced cognitive decline in aged mice (bone-fracture model) |
| Negative finding | NAD+ did not improve anesthetic recovery in a separate rodent study |
| Human trials | None published for surgical recovery or POCD outcomes |
The honest counterweight
This is one of the more clearly unsettled topics in this series. Even within animal research, results depend heavily on the specific model, anesthetic agent, and NAD+ precursor tested, and at least one relevant study found no benefit at all. No human trial has tested whether taking an NAD+ precursor before or after surgery improves cognitive outcomes, delirium risk, wound healing, or general recovery time. Claims implying otherwise outrun the current evidence.
When to see a doctor
If you have upcoming surgery, always tell your surgical and anesthesia team about every supplement you're taking, including NAD+ precursors, well before your procedure — some supplements can affect bleeding risk, drug metabolism, or interact with anesthesia, and this decision should be made with your care team, not independently.
What's actually proven to help surgical recovery
Prehabilitation (optimizing nutrition, activity, and smoking cessation before surgery), evidence-based enhanced-recovery-after-surgery (ERAS) protocols, adequate pain control, early mobilization after surgery, and delirium-prevention protocols in at-risk patients (including non-pharmacological approaches and, in some studies, perioperative melatonin) all have real supporting evidence.
How does this fit with other NAD+ tissue-recovery research?
Surgical recovery sits adjacent to the broader tissue-repair research covered in NAD+ and muscle recovery and the DNA-damage-response mechanisms discussed in NAD+ and DNA repair, both of which are more directly studied in humans than the surgical-recovery question specifically. If you're evaluating whether to start any NAD+ precursor supplement around a planned procedure, it's worth reviewing the full safety picture in our page on NAD+ supplement side effects before that conversation with your surgical team.
It's worth understanding why this research area is particularly hard to translate from animal to human data: anesthesia protocols, surgical stress, and patient age and frailty vary enormously between a controlled rodent study and a real hospital operating room, and postoperative cognitive outcomes in humans are influenced by dozens of factors (pain control, sleep disruption, medication interactions, underlying health conditions) that a mouse model can't fully replicate. That gap is exactly why the mixed animal findings described above haven't yet been followed by a definitive human trial in either direction.
Worth adding one more mechanistic detail: the bone-fracture mouse study specifically found that nicotinamide pretreatment worked by lowering CD38 and IL-1beta protein levels in hippocampal tissue — CD38 is a major NAD+-consuming enzyme that increases with age and inflammation, making it a plausible target for future, more targeted interventions. But a specific mechanism working in a controlled mouse fracture model is still a considerable distance from a proven human surgical-recovery benefit.
If you're specifically concerned about postoperative cognitive changes because of a personal or family history of dementia, or because you're an older adult facing a major surgery, this is worth raising directly and early with your surgical and anesthesia team, since they may already have protocols (like regional anesthesia when appropriate, or specific delirium-prevention bundles) tailored to reducing that risk using approaches with actual human trial support.
Given how early-stage and mixed this research area is, it's reasonable to treat any marketing claim connecting a specific NAD+ supplement product to surgical recovery with real skepticism until human trial data actually exists, regardless of how plausible the underlying cellular mechanism sounds on its own.
The safest approach heading into any surgery remains full disclosure of your complete supplement list to your surgical and anesthesia team well ahead of your procedure date, giving them time to flag anything that needs to be paused or adjusted beforehand.
Bring a complete written list of every supplement, dose, and how long you've been taking it to your pre-operative appointment so nothing gets missed in conversation.
Frequently asked questions
Should I take NAD+ supplements before or after surgery?
There's no human evidence supporting this specific use, and you should discuss any supplement with your surgical team before your procedure given potential interactions with anesthesia.
Does NAD+ prevent postoperative cognitive dysfunction?
Some animal studies show a protective effect and at least one shows no benefit; no human trial has tested this yet.
What's proven to reduce postoperative delirium risk?
Non-pharmacological prevention protocols and, per some meta-analyses, perioperative melatonin have shown risk reduction in trials; supplement-based NAD+ approaches have not been tested this way in humans.
From Nuvirox
Why we formulated NAD+ Restore
To be direct: NAD+ Restore is a general wellness supplement, not a treatment for this condition, and it shouldn't be used as a substitute for medical care. If you're separately interested in cellular energy support once your care team is in the loop, here's what's in it.
- 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials
- 150 mg trans-resveratrol (Japanese Knotweed) + 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support
- 10 mg galactomannans from fenugreek — to support absorption
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should
The bottom line: the biological rationale for NAD+ and surgical recovery is real, but the animal evidence is mixed rather than uniformly positive, and there's no human trial data at all. Tell your surgical team about any supplement use, and don't substitute this research for evidence-based perioperative care.
References
- Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice. PMID: 37931707.
- Nicotinamide Prevents the Plasticity Impairments and the Cognitive Dysfunction Caused by Bone Fracture in Older Mice. PMCID: PMC12363222.
- Nicotinamide Adenine Dinucleotide Does Not Improve Anesthetic Recovery in Rodents. PMCID: PMC11213214.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.